Bolivia QMS Certificate: ISO 13485 per Plant and the Two-Year Validity Standard
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Bolivia requires a GMP or equivalent quality system certificate, in the form of an original or a copy certified by the health authority, and the certificate must not exceed 2 years (Section 2.3.1 of the Manual). Two aspects of this requirement are routinely underestimated. The first is that every plant needs its own certificate, including the packaging plant; a single corporate-level certificate covering only the main manufacturing site does not satisfy the requirement for a multi-site supply chain. The second is that AGEMED retains the power to travel to the plant for inspection or to verify the certificate with the regulatory authority of the country of origin. GRZAN’s assessment is that the more complex the supply chain, the higher the cost of this requirement: contract manufacturing, repackaging and packaging at a separate location each add one more certificate to the set, together with its own certification and legalization chain. Companies should map their full plant network at the start of the project and budget for a certificate per functional site, rather than assuming that one document will carry the whole dossier through review. Because each certificate must be tracked separately, companies with multi-site supply chains should maintain a certificate register listing the plant, the issuing body, the issue date and the expiry relevant to Bolivia, so that no site silently falls out of compliance.
2. Legal basis
| Regulation | Reference number | Publication date | Provision |
|---|---|---|---|
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.3.1 |
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.2.3 |
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.3.2 |
| Resolución Ministerial (fees and procedures) | Resolución Ministerial N° 0265 | May 25, 2018 | Entire text |
3. Expert insights
Insight one: the 2-year validity standard does not match the 3-year ISO 13485 certification cycle. ISO 13485 certificates are typically valid for 3 years and are supported by annual surveillance audit records, while Bolivia accepts them for 2 years. This creates a practical question that many applicants fail to anticipate: how should a certificate be handled when it is still within its certification cycle but older than 2 years. GRZAN recommends controlling the age of the document by its issue date and proactively confirming the position with AGEMED before submission, so that a document which is formally valid under the certification scheme is not treated as stale under the Manual. The confirmation should be requested before the dossier is assembled, since it may determine whether a reissue is needed and how long it will take. Relying on the certificate’s own printed expiry date without checking the 2-year rule is one of the most frequent avoidable errors at this step. Where the surveillance audit schedule means the certificate will cross the 2-year line during review, the reissue should be commissioned early enough that the new document is available before any response deadline.
Insight two: packaging plants are listed separately, which shows that the definition of a plant is functional. Section 2.3.1 places packaging plants on the same footing as manufacturing plants, and this echoes the requirement in Section 2.2.3 to list all sites that produce, fill or package the finished product. When assembling documents, companies should not apply the mindset that there is only one manufacturer; instead, they should break the supply chain down by functional site. Each function that touches the finished product generates its own documentary obligation, and reviewers cross-check the certificate set against the plant list in the authorization page. A plant map that distinguishes design, manufacture, sterilization, filling and packaging functions gives reviewers an unambiguous picture and prevents the observation that a listed site lacks a certificate.
Insight three: AGEMED can verify in the reverse direction. The Manual expressly states that AGEMED may inspect the plant or seek confirmation from the regulatory authority of the country of origin. This means the authenticity and traceability of the certificate are live review concerns, not theoretical ones. The consequences of a forged or internally inconsistent certificate are severe, ranging from observations to rejection and damage to the credibility of every other filing made under the same company name. Any discrepancy in names, addresses or scope between the certificate and the rest of the dossier should be resolved at the source, by asking the certification body to correct the document. Companies should treat certificate accuracy as an absolute red line in dossier preparation.
4. Practical recommendations
- List all plants by functional site, covering production, filling and packaging, and prepare a quality system certificate for each one individually.
- Keep the certificate issue date within 2 years of submission, and arrange reissue in advance where the existing document would exceed the limit on the planned filing date.
- Ensure the company name and address on the certificate match the Section 2.2.3 information page word for word, because discrepancies can cause verification against the authority of origin to fail.
- Retain the surveillance audit records of the certification body alongside the certificate, so that AGEMED can be shown a continuous quality system history if questions arise during review, indexed by plant so that each site history can be produced quickly on request.
5. Verification checklist
- □ All functional sites, including the packaging plant, have been listed
- □ Each plant has its own quality system certificate
- □ Each certificate is within the 2-year validity standard
- □ The form of each certificate is an original or a certified copy
- □ The certificate information matches the Section 2.2.3 information page
Regulatory information verified as of October 29, 2026.
GRZAN provides registration support in Bolivia for manufacturers, importers and authorized representatives, covering quality system documentation, plant mapping, dossier preparation and regulatory correspondence. For assistance with quality system certificates and the full registration process, contact info@grzanglobal.com. Support extends to multi-site supply chains, where each functional plant requires its own certificate. Verification requests are also easier to answer when the certificate set and the plant list are reconciled before submission.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us